Dr. Michael Jason Moses, MD

Dr. Moses practices at Facey Endoscopy Center in Mission Hills, California.

Dr. Moses' NPI, 1316470818, was assigned on April 11, 2017. Dr. Moses graduated from New York University School of Medicine in 2017. Dr. Moses holds California license A186503.

Dr. Moses' primary practice is Facey Endoscopy Center, at 11333 Sepulveda Blvd, #3200, Mission Hills, CA 91345. The practice phone is (818) 837-5776.

Dr. Moses' primary practice is Facey Endoscopy Center in Mission Hills, California. Dr. Moses is also affiliated with Providence Saint Joseph Medical Center. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Moses to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Moses' employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moses practices, 4 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Moses' primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Moses is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Moses' licenses on file in 2 states: California and Ohio.

Dmand AI lists arthritis among the conditions Dr. Moses treats.

CMS data shows 2,700 Medicare services from Dr. Moses across 29 procedure codes in 2024, for 612 Medicare patients. Medicare paid $156,139 for them.

CMS counts 612 Medicare patients who saw Dr. Moses in 2024. The largest group is 65 to 74, with 277 patients. 75% of them have arthritis, and 75% have high blood pressure. 40% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moses' median patient age at 62, with 55% women.

In 2024, Dr. Moses wrote 249 Medicare Part D claims for 92 patients. 100% of them were for generic drugs. CMS names the drug for 199 of them, across 4 drugs with 11 or more claims each, at $757 in total drug cost. In 2023, CMS named 38 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Moses for performance year 2024, reported as part of a group. Dr. Moses accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Moses, published from 2015 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Knee Joint, Arthroplasty, Replacement, Knee and Cervical Vertebrae. Dr. Moses has published most often in Bull Hosp Jt Dis (2013). Dr. Moses' most frequent co-authors are Michael Moses, DO, Themistocles S. Protopsaltis, MD and Thomas J. Errico, MD.

CMS Open Payments shows 66 general payments to Dr. Moses from 11 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 81% of the total. Stryker Corporation paid the most, $1,422.

Dmand AI lists 3 awards for Dr. Moses, most recently Gold Humanism Honor Society in 2022.

Dr. Moses graduated from New York University School of Medicine in 2017. Dr. Moses is a member of AOA, AAOS and Phi Beta Kappa.

Dr. Moses is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.